Impact of Sirolimus-Eluting and Paclitaxel-Eluting Stents on Outcome in Patients With Diabetes Mellitus and Stenting in More Than One Coronary Artery-Reference-Cited by-同舟云学术

Impact of Sirolimus-Eluting and Paclitaxel-Eluting Stents on Outcome in Patients With Diabetes Mellitus and Stenting in More Than One Coronary Artery

Published:2006-08 Issue:3 Volume:98 Page:362-366
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Stankovic Goran,Cosgrave John,Chieffo Alaide,Iakovou Ioannis,Sangiorgi Giuseppe,Montorfano Matteo,Airoldi Flavio,Carlino Mauro,Michev Iassen,Finci Leo,Colombo Antonio

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Diabetes and coronary revascularization;Flaherty;JAMA,2005

2. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction;Prasad;J Am Coll Cardiol,2005

3. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients;West;Circulation,2004

4. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus;Hermiller;J Am Coll Cardiol,2005

5. Impact of sirolimus-eluting stents on outcome in diabetic patients;Moussa;Circulation,2004

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes following implantation of the ION™ paclitaxel‐eluting platinum chromium coronary stent in routine clinical practice: Results of the ION U.S. post‐approval study;Catheterization and Cardiovascular Interventions;2018-12-30

2. Managing Chronic Coronary Artery Disease in Patients with Diabetes;Chronic Coronary Artery Disease;2018

3. Percutaneous coronary intervention vs. cardiac surgery in diabetic patients. Where are we now and where should we be going?;Hellenic Journal of Cardiology;2017-05

4. Stent thrombosis and adverse cardiovascular outcomes observed between six months and five years with sirolimus-eluting stents and other drug-eluting stents in patients with Type 2 diabetes mellitus complicated by coronary artery disease;Medicine;2016-07

5. First-generation paclitaxel- vs. second-generation zotarolimus-eluting stents in small coronary arteries: the BASKET-SMALL Pilot Study;Advances in Interventional Cardiology;2016